Abstract:Indole-containing small molecules have been reported to have diverse pharmacological activities. The aromatic heterocyclic scaffold, which resembles various protein structures, has received attention from organic and medicinal chemists. Exploration of indole derivatives in drug discovery has rapidly yielded a vast array of biologically active compounds with broad therapeutic potential. Nature is the major source of indole scaffolds, but various classical and advanced synthesis methods for indoles have also been reported. One-pot synthesis is widely considered an efficient approach in synthetic organic chemistry and has been used to synthesize some indole compounds. The rapid emergence of drug-resistant tuberculosis is a major challenge to be addressed. Identifying novel targets and drug candidates for tuberculosis is therefore crucial. Researchers have extensively explored indole derivatives as potential anti-tubercular agents or drugs. Indole scaffolds containing the novel non-covalent (decaprenylphosphoryl-β-D-ribose2'-epimerase) DprE1 inhibitor 1,4-azaindole is currently in clinical trials to treat Mycobacterium tuberculosis. In addition, DG167 indazole sulfonamide with potent anti-tubercular activity is undergoing early-stage development in preclinical studies. Indole bearing cationic amphiphiles with high chemical diversity have been reported to depolarize and disrupt the mycobacterial membrane. Some indole-based compounds have potential inhibitory activities against distinct anti-tubercular targets, including the inhibition of cell wall synthesis, replication, transcription, and translation, as summarized in the graphical abstract. The success of computer-aided drug design in the fields of cancer and anti-viral drugs has accelerated in silico studies in antibacterial drug development. This review describes the sources of indole scaffolds, the potential for novel indole derivatives to serve as anti-tubercular agents, in silico findings, and proposed actions to facilitate the design of novel compounds with anti-tubercular activity.

Indole and indoline scaffolds in drug discovery

Research Status of Indole-Modified Natural Products

Indazole as a privileged scaffold in drug discovery

Indazole As a Privileged Scaffold: the Derivatives and Their Therapeutic Applications

Indole Derivatives: A Versatile Scaffold in Modern Drug Discovery—An Updated Review on Their Multifaceted Therapeutic Applications (2020–2024)

Development and Application of Indolines in Pharmaceuticals

Indole: A Privileged Scaffold for the Design of Anti-Cancer Agents

Research progress on the structure and biological diversities of 2-phenylindole derivatives in recent 20 years

Diverse Strategies for the Synthesis of the Indoline Scaffold

Indole-containing pharmaceuticals: targets, pharmacological activities, and SAR studies

Indole derivatives as agrochemicals: An overview

Design, synthesis and molecular docking studies of new indole scaffolds

Unlocking therapeutic potential: exploring indole scaffolds and their structural insights as pharmacophores in designing anti-breast cancer agents

The importance of indole and azaindole scaffold in the development of antitumor agents

Indole: A promising scaffold for the discovery and development of potential anti-tubercular agents

Exploring the decadal evolution of indolizine scaffold for anticancer innovations: a comprehensive analysis

Novel Indolo-Sophoridinic Scaffold As Topo I Inhibitors: Design, Synthesis and Biological Evaluation As Anticancer Agents

Indanone: a promising scaffold for new drug discovery against neurodegenerative disorders

Role of Indole Scaffolds as Pharmacophores in the Development of Anti-Lung Cancer Agents

Research progress of indole-fused derivatives as allosteric modulators: Opportunities for drug development

A brief review of the biological potential of indole derivatives